NASDAQ : LGVN
Longeveron Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1.67 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 5.32M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Longeveron Inc. (LGVN) reported revenue of 1.19M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 1.19M | 1.20M | 2.39M | 709.00K | 1.22M | 1.31M |
| Cost of Revenue | 359.00K | 396.00K | 508.00K | 488.00K | 725.00K | 716.00K |
| Gross Profit | 828.00K | 803.00K | 1.88M | 221.00K | 497.00K | 590.00K |
| Selling, General & Admin | 12.40M | 12.05M | 10.27M | 12.18M | 9.17M | 10.95M |
| Research & Development | 11.88M | 12.04M | 8.14M | 9.07M | 9.37M | 7.09M |
| Other Operating Expenses | -23.00K | -306.00K | -58.00K | |||
| Operating Expenses | 24.28M | 24.09M | 18.41M | 21.23M | 18.23M | 17.99M |
| Operating Income | -23.45M | -23.29M | -16.52M | -21.01M | -17.74M | -17.40M |
| Interest Expense | -4.00K | |||||
| Interest & Investment Income | 337.00K | 400.00K | 60.00K | |||
| Currency Exchange Gain (Loss) | 27.00K | |||||
| Other Non Operating Income (Expenses) | -359.00K | -20.00K | 549.00K | 213.00K | 273.00K | -20.00K |
| EBT Excluding Unusual Items | -23.48M | -22.91M | -15.97M | -20.79M | -17.44M | -17.36M |
| Gain (Loss) on Sale of Investments | -300.00K | 17.00K | ||||
| Gain (Loss) on Sale of Assets | -97.00K | -97.00K | ||||
| Asset Writedown | -200.00K | -290.00K | ||||
| Legal Settlements | -30.00K | -1.40M | ||||
| Other Unusual Items | 300.00K | 300.00K | 300.00K | |||
| Pretax Income | -23.47M | -22.70M | -15.97M | -21.41M | -18.84M | -17.05M |
| Net Income | -23.47M | -22.70M | -15.97M | -21.41M | -18.84M | -17.05M |
| Preferred Dividends & Other Adjustments | 8.65M | 798.00K | ||||
| Net Income to Common | -23.47M | -22.70M | -24.62M | -22.21M | -18.84M | -17.05M |
| Shares Outstanding (Basic) | 2.41M | 1.76M | 941.12K | 217.35K | 209.69K | 189.15K |
| Shares Outstanding (Diluted) | 2.41M | 1.76M | 941.12K | 217.35K | 209.69K | 189.15K |
| EPS (Basic) | -9.73 | -12.92 | -26.16 | -102.19 | -89.82 | -90.11 |
| EPS (Diluted) | -9.73 | -12.92 | -26.16 | -102.19 | -89.82 | -90.11 |
| Free Cash Flow | -20.53M | -18.89M | -14.52M | -19.30M | -14.54M | -9.97M |
| Free Cash Flow Per Share | -8.51 | -10.75 | -15.43 | -88.81 | -69.33 | -52.69 |
| Gross Margin | 69.76% | 66.97% | 78.76% | 31.17% | 40.67% | 45.18% |
| Operating Margin | -1,975.99% | -1,942.20% | -690.72% | -2,962.76% | -1,451.47% | -1,332.16% |
| Profit Margin | -1,977.59% | -1,893.58% | -1,029.39% | -3,132.72% | -1,541.33% | -1,305.13% |
| Free Cash Flow Margin | -1,729.91% | -1,575.48% | -607.15% | -2,722.57% | -1,189.69% | -763.09% |
| EBITDA | -22.44M | -22.06M | -15.56M | -20.06M | -16.84M | -16.48M |
| D&A For EBITDA | 1.01M | 1.23M | 958.00K | 946.00K | 893.00K | 914.00K |
| EBIT | -23.45M | -23.29M | -16.52M | -21.01M | -17.74M | -17.40M |
| Revenue as Reported | 1.19M | 1.20M | 2.39M | 709.00K | 1.22M | 1.31M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 10.08M | 4.66M | 19.23M | 4.95M | 10.50M | 25.66M |
| Short-Term Investments | 412.00K | 9.15M | 9.38M | |||
| Cash & Short-Term Investments | 10.08M | 4.66M | 19.23M | 5.36M | 19.66M | 35.04M |
| Receivables | 65.00K | 104.00K | 84.00K | 111.00K | 218.00K | 55.00K |
| Prepaid Expenses | 1.18M | 686.00K | 308.00K | 376.00K | 404.00K | 282.00K |
| Total Current Assets | 11.32M | 5.45M | 19.62M | 5.85M | 20.28M | 35.38M |
| Property, Plant & Equipment | 1.95M | 2.35M | 3.33M | 3.75M | 4.48M | 4.88M |
| Other Intangible Assets | 2.20M | 2.29M | 2.40M | 2.29M | 2.41M | 2.33M |
| Other Long-Term Assets | 12.00K | 176.00K | 202.00K | 193.00K | 244.00K | 177.00K |
| Total Assets | 15.49M | 10.26M | 25.56M | 12.08M | 27.41M | 42.77M |
| Accounts Payable | 633.00K | 423.00K | 99.00K | 638.00K | 1.75M | 645.00K |
| Accrued Expenses | 2.65M | 2.97M | 1.82M | 2.15M | 650.00K | 1.33M |
| Current Portion of Leases | 581.00K | 655.00K | 623.00K | 593.00K | 564.00K | 537.00K |
| Current Unearned Revenue | 40.00K | 40.00K | 40.00K | 506.00K | 506.00K | 199.00K |
| Other Current Liabilities | 400.00K | 1.40M | ||||
| Total Current Liabilities | 4.31M | 4.09M | 2.58M | 3.89M | 4.87M | 2.71M |
| Long-Term Leases | 169.00K | 824.00K | 1.45M | 2.04M | 2.60M | |
| Other Long-Term Liabilities | 778.00K | 330.00K | 265.00K | |||
| Total Liabilities | 5.08M | 4.59M | 3.67M | 5.34M | 6.91M | 5.31M |
| Common Stock | 31.00K | 22.00K | 14.00K | 2.00K | 21.00K | 21.00K |
| Additional Paid-In Capital | 153.49M | 137.96M | 131.48M | 91.82M | 83.71M | 81.47M |
| Retained Earnings | -143.12M | -132.31M | -109.61M | -84.98M | -62.77M | -43.94M |
| Comprehensive Income & Other | -100.00K | -457.00K | -100.00K | |||
| Shareholders' Equity | 10.40M | 5.67M | 21.89M | 6.74M | 20.50M | 37.45M |
| Total Liabilities & Equity | 15.49M | 10.26M | 25.56M | 12.08M | 27.41M | 42.77M |
| Total Debt | 581.00K | 824.00K | 1.45M | 2.04M | 2.60M | 3.14M |
| Net Cash (Debt) | 9.50M | 3.84M | 17.79M | 3.32M | 17.05M | 31.90M |
| Net Cash Per Share | 3.93 | 2.18 | 18.90 | 15.27 | 81.32 | 168.65 |
| Filing Date Shares Outstanding | 3.19M | 2.33M | 1.50M | 251.35K | 210.34K | 209.12K |
| Total Common Shares Outstanding | 3.17M | 2.29M | 1.49M | 251.07K | 210.18K | 208.78K |
| Working Capital | 7.02M | 1.36M | 17.04M | 1.96M | 15.41M | 32.67M |
| Book Value Per Share | 3.28 | 2.47 | 14.70 | 26.85 | 97.55 | 179.39 |
| Tangible Book Value | 8.20M | 3.39M | 19.49M | 4.45M | 18.09M | 35.12M |
| Tangible Book Value Per Share | 2.59 | 1.48 | 13.09 | 17.74 | 86.09 | 168.21 |
| Machinery | 3.35M | 3.21M | 3.18M | 2.60M | 1.75M | |
| Leasehold Improvements | 4.41M | 4.41M | 4.40M | 4.33M | 4.32M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -23.47M | -22.70M | -15.97M | -21.41M | -18.84M | -17.05M |
| Depreciation & Amortization | 1.01M | 1.23M | 958.00K | 946.00K | 893.00K | 914.00K |
| Loss (Gain) From Sale of Assets | 97.00K | 97.00K | 60.00K | |||
| Asset Writedown & Restructuring Costs | 290.00K | |||||
| Loss (Gain) From Sale of Investments | 85.00K | |||||
| Stock-Based Compensation | 1.58M | 1.68M | 2.33M | 2.03M | 2.17M | 7.74M |
| Other Operating Activities | 60.00K | 220.00K | 1.57M | -300.00K | ||
| Change in Accounts Receivable | -34.00K | -20.00K | 27.00K | 107.00K | -164.00K | 366.00K |
| Change in Accounts Payable | -66.00K | 325.00K | -540.00K | -1.11M | 1.11M | -945.00K |
| Change in Unearned Revenue | -466.00K | 307.00K | 188.00K | |||
| Change in Other Net Operating Assets | 512.00K | 754.00K | -262.00K | -71.00K | -1.01M | -699.00K |
| Operating Cash Flow | -20.37M | -18.64M | -13.87M | -19.00M | -13.97M | -9.64M |
| Capital Expenditures | -160.00K | -245.00K | -655.00K | -301.00K | -569.00K | -330.00K |
| Sale of Property, Plant & Equipment | 85.00K | |||||
| Sale (Purchase) of Intangibles | -145.00K | -350.00K | -337.00K | -393.00K | -287.00K | -980.00K |
| Investment in Securities | 352.00K | 8.88M | 179.00K | -9.47M | ||
| Investing Cash Flow | -305.00K | -595.00K | -640.00K | 8.19M | -677.00K | -10.70M |
| Short-Term Debt Repaid | -38.00K | |||||
| Long-Term Debt Repaid | -150.00K | |||||
| Total Debt Repaid | -188.00K | |||||
| Net Debt Issued (Repaid) | -188.00K | |||||
| Issuance of Common Stock | 19.80M | 4.98M | 29.16M | 5.44M | 2.00K | 45.81M |
| Repurchase of Common Stock | -272.00K | -311.00K | -366.00K | -174.00K | -304.00K | -451.00K |
| Other Financing Activities | 890.00K | -207.00K | ||||
| Financing Cash Flow | 20.42M | 4.67M | 28.79M | 5.26M | -509.00K | 45.17M |
| Net Cash Flow | -257.00K | -14.57M | 14.28M | -5.55M | -15.15M | 24.84M |
| Free Cash Flow | -20.53M | -18.89M | -14.52M | -19.30M | -14.54M | -9.97M |
| Free Cash Flow Margin | -1,729.91% | -1,575.48% | -607.15% | -2,722.57% | -1,189.69% | -763.09% |
| Free Cash Flow Per Share | -8.51 | -10.75 | -15.43 | -88.81 | -69.33 | -52.69 |
| Levered Free Cash Flow | -11.60M | -11.17M | -9.27M | -11.72M | -7.03M | -3.81M |
| Unlevered Free Cash Flow | -11.60M | -11.17M | -9.27M | -11.72M | -7.03M | -3.80M |
| Change in Working Capital | 412.00K | 1.06M | -1.24M | -1.08M | 238.00K | -1.09M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 5.58M | 10.79M | 25.67M | 34.15M | 67.68M | 244.90M |
| Enterprise Value | -3.92M | 2.53M | 4.49M | 32.40M | 48.10M | 229.35M |
| Last Close Price | 1.67 | 5.06 | 17.30 | 136.00 | 322.00 | 1,207.00 |
| PS Ratio | 4.49 | 9.00 | 10.73 | 48.16 | 55.38 | 187.52 |
| PB Ratio | 0.51 | 1.90 | 1.17 | 5.07 | 3.30 | 6.54 |
| P/TBV Ratio | 0.65 | 3.18 | 1.32 | 7.67 | 3.74 | 6.97 |
| EV/Sales Ratio | 2.11 | 1.88 | 45.70 | 39.37 | 175.61 | |
| Debt / Equity Ratio | 0.06 | 0.14 | 0.07 | 0.30 | 0.13 | 0.08 |
| Net Debt / Equity Ratio | -0.91 | -0.68 | -0.81 | -0.49 | -0.83 | -0.85 |
| Net Debt / EBITDA Ratio | 0.42 | 0.17 | 1.14 | 0.17 | 1.01 | 1.94 |
| Net Debt / FCF Ratio | 0.46 | 0.20 | 1.23 | 0.17 | 1.17 | 3.20 |
| Asset Turnover | 0.07 | 0.07 | 0.13 | 0.04 | 0.04 | 0.05 |
| Quick Ratio | 2.35 | 1.17 | 7.48 | 1.41 | 4.08 | 12.96 |
| Current Ratio | 2.63 | 1.33 | 7.60 | 1.50 | 4.17 | 13.06 |
| Return on Equity (ROE) | -203.61% | -164.75% | -111.59% | -157.19% | -65.00% | -86.50% |
| Return on Assets (ROA) | -90.95% | -81.27% | -54.87% | -66.49% | -31.59% | -41.82% |
| Return on Capital Employed (ROCE) | -209.80% | -377.20% | -71.90% | -256.50% | -78.70% | -43.40% |
| Earnings Yield | -555.77% | -210.33% | -62.23% | -62.71% | -27.83% | -6.96% |
| FCF Yield | -385.67% | -175.00% | -56.58% | -56.53% | -21.48% | -4.07% |
| Buyback Yield / Dilution | -64.79% | -86.76% | -333.00% | -3.65% | -10.86% | -18.05% |